Blockchain Registration Transaction Record

Calidi Biotherapeutics Appoints Eric Poma, PhD, as New CEO

Calidi Biotherapeutics names Eric Poma, PhD, as CEO to lead innovative cancer therapy development. A leap forward in oncology treatment.

Calidi Biotherapeutics Appoints Eric Poma, PhD, as New CEO

This news is significant as it highlights a pivotal leadership change at Calidi Biotherapeutics, a company pioneering innovative cancer treatments. Dr. Poma's appointment could accelerate the development and commercialization of Calidi's therapies, potentially offering new hope for patients with high-grade gliomas and solid tumors. The advancements in targeted antitumor virotherapies represent a breakthrough in oncology, emphasizing the importance of this development for the medical community and patients alike.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x01d04fe90f06476203fab75b6c7a9549f6f67678c52bb5d80da988c921ce3eb3
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintbake98sA-8b8a89c5d8de859cc8fcffefbe73e372